NKMax America, Inc. is a biotech company specializing in both autologous and allogenic Natural Killer (NK) cell therapy utilizing our proprietary cell expansion and cell activation technology.  This therapeutic technology was developed as a complement to ATGen's first-in-kind in vitro diagnostic test which measures NK cell activity using only 1 ml blood.